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Insurer
Open
Procedure EVI
AKA/
BKA
Admission
For
Gangrene
Private pay (PP) 21% 221% 162% 214% 213%
Medicare 68% 217% 1101% 211% 25%
Medicaid 9% 224% 1115% 214% 227%
Uninsured (UI) 1% 18% 138% 17% 135%
Significance P  .001 P  .03 P  .04 P  .001
AKA/BKA; Above the knee amputation/below the knee amputation; EVI,
endovascular intervention.
Hydrogen Sulfide Prevents Ischemia-Reperfusion Injury in Muscle
even when Delivered in the Post-ischemic Period
Henderson PW, Singh SP, Weinstein AL, Nagineni V, Spector JA
Objectives: Ischemia-reperfusion injury (IRI) is an unavoidable con-
sequence of revascularization following acute vascular occlusion. Hydrogen
sulfide (H2S) is now recognized as an endogenous signaling molecule, and
recent work from our lab has shown that H2S mitigates IRI in muscle when
delivered prior to the onset of ischemia. The purpose of this study was to
determine whether H2S confers a similar protective effect when delivered
after an ischemic event has occurred.
Methods:Nine C57/BL6 mice underwent three hours of tourniquet-
induced hind limb ischemia and were randomized to three groups: no H2S,
10M intravenous H2S delivered one minute prior to reperfusion, and
10M H2S delivered 20 minutes prior to reperfusion. After three hours of
reperfusion, the gastrocnemius and soleus muscles were harvested bilater-
ally. Sections were stained with hematoxylin and eosin (H&E) and subjected
to a terminal deoxynucleotidyl transferase dUTP nick end labeling
(TUNEL) assay. Values are reported as mean SE, and student t tests were
performed compared to non-H2S-treated mice. Statistical significance was
set at P  .05.
Results:Upon histologic examination, ischemic tissue from non-H2S-
treated mice had architectural changes including extracellular edema and
intracellular vacuolization; tissue from mice treated with H2S one minute
prior to reperfusion was similar in appearance (Fig). Ischemic tissue from
mice treated with H2S 20 minutes prior to reperfusion showed no evidence
of architectural changes. Non-ischemic tissue treated with H2S was not
different in appearance from non-ischemic, non-treated tissue. The percent-
age of apoptotic cells was significantly reduced by treating mice with H2S 20
minutes prior to reperfusion, but not when H2S was delivered one minute
prior (18.1%  11.0% in non-HS-treated mice, 1.8%  1.4% [P  .026] in
mice treated with H2S 20 minutes prior to reperfusion, and 16.0%  7.7%
[P  .771] in mice treated with H2S one minute prior to reperfusion).
Conclusions: After an ischemic insult has occurred, H2S protects
against IRI when delivered 20 minutes, but not one minute, prior to
reperfusion. This suggests the mechanism by which H2S functions requires
equilibration prior to reperfusion. The absence of injury in non-ischemic
H2S-treated tissue suggests that H2S is non-toxic at the dose tested in this
study (10 M). We conclude that H2S may have clinical application as a
component of therapeutic revascularization regimens.
Endothelial Cells with Eph B4 Heterozygous Knockdown: A Novel
Model for Vein Graft Adaptation
Feigel A, Muto A, Fancher T, et al
Objectives: Vein graft adaptation (VGA) is characterized by vein wall
thickening, a complex process requiring cell proliferation and migration. We
have previously shown that VGA is also associated with loss of the venous
determinant Eph-B4. To study molecular mechanisms that mediate VGA,
we developed a novel in vitro model of VGA.Methods: Aortic interposition grafts were examined using veins from
wild type (WT) and Eph-B4 heterozygous knockout (Eph-B4-KO) mice.Endothelial cells (EC) were isolated from both WT and Eph-B4-KO mice.
Cell proliferation was directly counted. Quantitative polymerase chain reac-
tion (qPCR) was used to evaluate basal mRNA expression. Western blot was
used to evaluate protein levels. Cell migration was evaluated using a Boyden
chamber.
Results: Vein grafts from Eph-B4-KO mice had 50% increased intimal
thickness compared with vein grafts from WT mice (P  .01). Under basal
conditions, Eph-B4-KO cells proliferated 41% more slowly than WT EC
(P  .029), and 43% more slowly when stimulated with Ephrin-B2/Fc.
Basal protein expression of Akt was 29% higher, and vascular endothelial
growth factor (VEGF)-A was 28% lower in Eph-B4-KO cells compared with
WT EC. Under direct stimulation, levels of phosphorylated AKT and
phosphorylated ERK 1/2 were greater in Eph-B4-KO cells. qPCR con-
firmed 49% less VEGF-A mRNA expression in Eph-B4-KO cells. Eph-
B4-KO cells had 60% reduced cell migration in response to Ephrin-B2/Fc
(P  .005).
Conclusions: EC isolated from Eph-B4-KO mice serve as a novel in
vitro model of VGA. This model suggests that reduced Eph-B4 expression
during VGAmay bemediated by upstream signals such as VEGF-A as well as
downstream pathways such as Akt.
The Effect of Tortuosity on Five Different Cerebral Protection Devices
in an Ex-vivo Model
Shah AR, Lipsitz EC, Scher L, et al
Objectives: To compare the efficacy and ease of deployment for five
currently available cerebral protection devices at varying degrees of tortuos-
ity.
Methods: An ex-vivo study using procured canine carotid arteries was
performed using an open flow model with three anatomical variants (non-
tortuous, mildly tortuous, and severely tortuous) and two embolic particle
sizes (250 and 425 microns). Cerebral protection devices (Accunet
[Guidant Corporation, Santa Clara, Calif], Angioguard [Cordis, Miami
Lakes, Fla], Emboshield [Abbott Laboratories, Abbott Park, III], Filterwire
EZ [Boston Scientific Corporation, Natick, Mass], and SpideRX [ev3, Inc,
Plymouth, Minn]) were placed under fluoroscopy at the point of maximal
inflection in the case of tortuous vessels. A total of 1.5 mg ( 0.05 mg) of
polyvinyl alcohol (PVA) particles of either size was injected into the carotid
system proximal to each of five protection devices at each of the three
degrees of tortuosity. Particles captured by the filters were weighted and
compared with the weight of the particles collected in the effluent filter (not
captured). The time taken to deploy each device at this position was
recorded.
Results: The percent capture for each of the five filters at each degree
of tortuosity using 425 micron particles is shown in the Fig. Similar results
were obtained for the 250 micron particles. Filterwire EZ and SpiderX were
deployed within the 26 to 27 second range. All others were deployed
between 30 and 36 seconds.
Conclusions: No filter completely prevented embolization. Filterwire
EZ, Accunet, and Angioguard exhibited the highest capture rates in straight
anatomy. Angioguard was the most efficacious filter in tortuous anatomy.
Increasing tortuosity had a significant negative impact on all filters. Filter-
wire EZ and SpiderX had the best trackability in tortuous vessels using this
model.
Mechanical Stimulation of HUVEC: Different Flow Patterns have
Differential Effects on TF Expression
Nixon AM, Rochier A, Yamashita N, Sumpio BE
Objectives: Human umbilical vein endothelial cells (HUVECs) are
known to respond differentially to various mechanical stimuli, and these
different responses maybe involved in atherogenesis. Here we investigated
the differential effects of different flow patterns, such as laminar flow (LF)
and orbital shear stress (OSS), on the expression of tissue factor (TF).
Methods:HUVECs were seeded on fibronectin coated glass slides and
selectively in the periphery of gelatin coated culture dishes. When HUVECs
on slides reached confluence, they were exposed to two, four, or six hours of
LF (14 dynes/cm2). HUVECs in culture dishes were exposed to the same
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was generated by placing dishes on an orbital shaker. TF mRNA levels were
quantified with reverse transcription polymerase chain reaction (RT-PCR),
with b-actin as the reference gene. Fold changes are expressed as the mean
SE. Statistical significance between treated groups and controls was evalu-
ated using the Mann-Whitney test. Analysis of variance (ANOVA) and
Tamhane’s post-hoc analysis were employed for between group analysis and
P  .05 was considered significant.
Results: Fold changes as compared with controls are summarized in the
Table andFig (P values are in brackets). LF resulted in significant increases inTF
expression throughout the six-hour time course when compared with static
controls. However no significant differences were noted between the two, four,
and six-hour LF groups. BothHOSS and LOSS reduced TFmRNA levels with
significance attained at four and six hours respectively.No significant differences
were observed between the different OSS groups.
Conclusions: LF induced a significant increase of TF mRNA levels.
Interestingly both high and low levels of OSS seemed to decrease TF
expression after two hours. These data demonstrate that different flow
patterns have differential effects on the expression of TF in HUVEC,
indicating the involvement of different intracellular signaling pathways.
Current efforts are focused on the interaction of flow patterns with chemical
stimulation, as a means of elucidating the intracellular signal conduction
pathway.
Table. TF expression fold changes compared with controls
N 6 HOSS LOSS LF
2 hrs 1.17  0.15 (.80) 1.34  0.37 (.21) 10.44  6.63 (.002)
4 hrs 0.67  0.05 (.001) 0.64  0.1 (.08) 9.34  3.8 (.002)
6 hrs 0.73  0.15 (.07) 0.69  0.18 (.03) 5.00  1.32 (.056)
HOSS, High orbital sheer stress; LF, laminar flow; LOSS, low orbital sheer
stress; TF, tissue factor.
Fig. HOSS, High orbital sheer stress; LF, laminar flow; LOSS,
low orbital sheer stress.
Evaluating Changes in Regional Tissue Perfusion Following Percuta-
neous Lower Extremity Revascularization Procedures with a Hyper-
spectral Image-based Tissue Oxygenation Mapping System
Mukherjee D, Johnson ON III, Hashemi HA, Bade MA, Guo SS, Aryavand B
Objectives: To establish the feasibility of using applied imaging spec-
troscopy to replace or supplement existing adjuncts in the evaluation of
patients with chronic limb ischemia undergoing percutaneous revasculariza-
tions.
Methods: This is an ongoing prospective study of a commercially
available hyperspectral imaging (HSI) camera, enrolling patients undergo-
ing endovascular procedures for chronic limb ischemia. Images of the dorsal
surface of the foot are obtained across various wavelengths of light before
and after intervention. Spectroscopic data are used to measure capillary
oxyhemoglobin, deoxyhemoglobin, and oxygen saturation (StO2) values.
These data are displayed as interactive digital color maps, demonstrating
heterogeneous perfusion throughout the entire foot and allowing morpho-
logic and quantitative analysis. Periprocedural changes are compared against
existing noninvasive tests. Revascularized patients are re-imaged at regular
intervals for up to one year post-procedure.Results: Of 25 enrolled patients having lower extremity limbs amena-
ble to endovascular treatment (Rutherford grades 1-4), 15 subjects (17
limbs) completed their pre- and post-procedure visits. Of these, 11 subjects
(13 limbs) also completed their six week and three month visits. All limbs
demonstrated a post-procedural change in their HSI profile. There was a
statistically significant increase in StO2 following revascularization that
persists at three months (from 32%  2% to 41%  9%, P  .01). The
increase corresponds with an increase in the ankle-brachial index (ABI),
which also persists at three months (0.75  0.06 to 0.94  0.05, P  .02).
The increase in StO2 predominantly resulted from 32% average decrease in
Hb-Deoxy (60  4 to 41  4, P  .004). Total hemoglobin in tissue also
decreased following treatment (90  7 to 70  6, P  .04).
Conclusions: HSI is an effective noninvasive imaging modality in the
assessment of peripheral perfusion after percutaneous lower extremity revas-
cularization procedures. The ease of use, precision of regionally discrete
data, and strong correlation with widely-accepted noninvasive measures
such as ABI suggests that HSI will be a valuable addition to the vascular lab.
Aorto Atrial AV Prosthetic Graft for Hemodialysis Access in a Patient
with Innominate and Bilateral Iliac Vein Thrombosis: A Case Report
and Review of Literature
Kella VK, Jamil Z, Krause T, Schor J, Cosgrove J
Objectives:Hemodialysis for end-stage renal disease requires access to
the patient’s circulating blood volume. Long term adequate hemodialysis is
best achieved with the native arteriovenous fistula, or a prosthetic bridging
graft. Central venous obstruction is a common problem, and presents a
challenge in terms of vascular access for these patients. Direct shunt between
subclavian artery and right atrium has been described. We present the first
case of aorto right atrial graft for dialysis access in a patient with innominate
and bilateral iliac vein thrombosis.
Methods: A 40-year-old African American female with history of HIV
and end stage renal disease (ESRD) on hemodialysis (HD). She hadmultiple
access procedures with recurrent thrombotic episodes. Onemonth prior, she
had right lower extremity prosthetic arterio venous graft that was placed
along with an indwelling temporary dialysis catheter in the same leg. She had
a febrile course along with infection of the prosthetic graft with prulent
discharge from the groin incision. She was treated with antibiotics and the
graft with the dialysis catheter was removed. Attempts at placing a new
catheter were unsuccessful and venography demonstrated occlusion of the
bilateral iliac veins .Peritoneal dialysis was started. After negative blood
cultures, an ascending aorta to right atrial AV graft with an 8 mm polytet-
rafluoroethylene (PTFE) graft was performed. The graft supported the
hemodialysis needs of the patient.
Results: At six-month follow-up, she is doing well with patent aorto
atrial graft.
Conclusions: Aorto atrial graft can provide successful hemodialysis in
patients with central vein obstruction and can be considered when all other
options have been exhausted. This is the first case of its kind for dialysis access.
Aortic Endograft Infection with Aortoduodenal Fistula Associated with
Adjacent Vertebral Body Mycobacterial Osteomyelitis (Pott’s Disease)
Solomon B, Plitas G, Bauer S, Rousou L, Jacobowitz G
Objectives: Aortoenteric fistulae (AEF) are a rare complication of
infrarenal abdominal aortic aneurysm (IAAA) repair. These fistulae, which
occur in1% of aortic grafting procedures, result from graft defects, foreign
bodies, and trauma, and are associated with a high mortality rate. Here we
report a complex AEF associated with vertebral body osteomyelitis likely
secondary to tuberculous infection.
Methods: A 78-year-old male presented with a two-week history of
abdominal pain, fever, and anemia (Hgb  6.9). Past surgical history is
significant for open repair of IAAA followed later by an endovascular repair
of a proximal para-anastamotic aneurysm. Computed tomography (CT)
angiography revealed air in the aneurysm sac consistent with infection.
There was no evidence of endoleak. The posterior aspect of the aneurysm
was noted to be in continuity with a destructive osteomyelitis of the L2
vertebral body and an adjacent psoas abscess.
Results: Percutaneous drainage and bacterial culture of the psoas
abscess and aneurysm sac revealed purulent fluid containing mixed enteric
flora. With fluoroscopic guidance, injection of contrast in the aortic sac
drainage catheter demonstrated complex fistulous communications from the
aortic sac to the overlying small intestine (Fig). After a course of drainage,
antibiotic therapy, and parenteral nutrition, the patient underwent a trans-
peritoneal repair of AEF and wide debridement of the aortic sac. The
periaortic tissue appeared fibronecrotic, consistent with a chronic inflamma-
tory process. Pathology revealed giant cell granulomas and necrotizing
epithelioid granulomatous formation, highly suggestive of tuberculosis. The
patient’s tuberculin skin test was positive. The patient recovered and was
discharged after six weeks of enteric feeding and nutritional repletion.
